Evidence map›Paper›PMID 32606667›Full record

ArticleInternational journal of nanomedicine2020

Rotating Magnetic Nanoparticle Clusters as Microdevices for Drug Delivery.

Alexander J Willis, Sebastian P Pernal, Zachary A Gaertner, Sajani S Lakka, Michael E Sabo, Francis M Creighton, Herbert H Engelhard

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexander J WillisDivision of Hematology-Oncology, Department of Medicine, The University of Illinois at Chicago, Chicago, IL, USA.
Sebastian P PernalWayne State University, Detroit, MI, USA.ORCID 0000-0001-9884-5703
Zachary A GaertnerNorthwestern University, Chicago, IL, USA.ORCID 0000-0002-1760-6549
Sajani S LakkaDivision of Hematology-Oncology, Department of Medicine, The University of Illinois at Chicago, Chicago, IL, USA.
Michael E SaboPulse Therapeutics, Inc, St. Louis, MO, USA.
Francis M CreightonPulse Therapeutics, Inc, St. Louis, MO, USA.
Herbert H EngelhardDepartments of Neurosurgery and Bioengineering, The University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0003-4993-9265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMagnetic nanoparticles (MNPs) hold promise for enhancing delivery of therapeutic agents, either through direct binding or by functioning as miniature propellers. Fluid-filled conduits and reservoirs within the body offer avenues for MNP-enhanced drug delivery. MNP clusters can be rotated and moved across surfaces at clinically relevant distances in response to a rotating magnet. Limited data are available regarding issues affecting MNP delivery by this mechanism, such as adhesion to a cellular wall. Research reported here was initiated to better understand the fundamental principles important for successful implementation of rotational magnetic drug targeting (rMDT).

methodsTranslational movements of four different iron oxide MNPs were tested, in response to rotation (3 Hz) of a neodymium-boron-iron permanent magnet. MNP clusters moved along biomimetic channels of a custom-made acrylic tray, by surface walking. The effects of different distances and cellular coatings on MNP velocity were analyzed using videography. Dyes (as drug surrogates) and the drug etoposide were transported by rotating MNPs along channels over a 10 cm distance.

resultsMNP translational velocities could be predicted from magnetic separation times. Changes in distance or orientation from the magnet produced alterations in MNP velocities. Mean velocities of the fastest MNPs over HeLa, U251, U87, and E297 cells were 0.24 ± 0.02, 0.26 ± 0.02, 0.28 ± 0.01, and 0.18 ± 0.03 cm/sec, respectively. U138 cells showed marked MNP adherence and an 87.1% velocity reduction at 5.5 cm along the channel. Dye delivery helped visualize the effects of MNPs as microdevices for drug delivery. Dye delivery by MNP clusters was 21.7 times faster than by diffusion. MNPs successfully accelerated etoposide delivery, with retention of chemotherapeutic effect.

conclusionThe in vitro system described here facilitates side-by-side comparisons of drug delivery by rotating MNP clusters, on a human scale. Such microdevices have the potential for augmenting drug delivery in a variety of clinical settings, as proposed.

Indexed as

RotationBiological TransportCell DeathCell Line, TumorDiffusionDrug Delivery SystemsEtoposideHumansMagnetite NanoparticlesMicrospheresMicrotechnologyParticle SizeTomography, X-Ray ComputedEtoposideMagnetite Nanoparticlesetoposideglioblastomain vitro modeliron oxide nanoparticleslung cancermagnetic drug targetingnanodevice

Identifiers

PMID32606667
PMCPMC7295537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.